Retinopathy of prematurity (ROP) is the most prevalent causes of blindness in premature babies. According to UN survey, 11.1% (~15M/year) of global live-births are premature. 60% of these are at risk for ROP. Even normal births have a 2% risk. Treatment — only possible within weeks of birth — requires diagnosis, traditionally with an indirect ophthalmoscope. Doctors with this diagnostic skill are few in the world, and fewer in India. A rural technician with a suitable retinal camera can transmit images to urban specialists, making universal diagnosis possible. But the device already available for this purpose costs USD110K. 3nethra neo addresses the primary cause why ROP isn’t yet a fully correctable disease: high cost of screening system. It is fast responsive, intuitive, ergonomic, light weight and is available at an affordable cost. Neo captures high quality, full color images of the pre-term eye with minimal discomfort to the baby and also identifies retinoblastoma and glaucoma